Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma

Name: Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma
License: Public Domain

AIO-Studien-gGmbH

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

transitional cell carcinoma, advanced cancer, metastatic cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 307465
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.